SI1276759T1 - Postopek reduktivnega alkiliranja na glikopeptidih - Google Patents

Postopek reduktivnega alkiliranja na glikopeptidih

Info

Publication number
SI1276759T1
SI1276759T1 SI200130870T SI200130870T SI1276759T1 SI 1276759 T1 SI1276759 T1 SI 1276759T1 SI 200130870 T SI200130870 T SI 200130870T SI 200130870 T SI200130870 T SI 200130870T SI 1276759 T1 SI1276759 T1 SI 1276759T1
Authority
SI
Slovenia
Prior art keywords
reductive alkylation
glycopeptides
alkylation process
saccharide
amines
Prior art date
Application number
SI200130870T
Other languages
English (en)
Inventor
Martin S Linsell
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of SI1276759T1 publication Critical patent/SI1276759T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SI200130870T 2000-05-02 2001-05-01 Postopek reduktivnega alkiliranja na glikopeptidih SI1276759T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20117800P 2000-05-02 2000-05-02
US21314800P 2000-06-22 2000-06-22
EP01930978A EP1276759B1 (en) 2000-05-02 2001-05-01 Reductive alkylation process on glycopeptides
PCT/US2001/014017 WO2001083521A2 (en) 2000-05-02 2001-05-01 Reductive alkylation process on glycopeptides

Publications (1)

Publication Number Publication Date
SI1276759T1 true SI1276759T1 (sl) 2008-12-31

Family

ID=26896472

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130870T SI1276759T1 (sl) 2000-05-02 2001-05-01 Postopek reduktivnega alkiliranja na glikopeptidih

Country Status (13)

Country Link
US (1) US6831150B2 (sl)
EP (1) EP1276759B1 (sl)
JP (2) JP4713810B2 (sl)
KR (1) KR100856479B1 (sl)
CN (1) CN100532392C (sl)
AT (1) ATE402951T1 (sl)
AU (1) AU2001257464A1 (sl)
CA (1) CA2407994C (sl)
DE (1) DE60135102D1 (sl)
ES (1) ES2311014T3 (sl)
NO (1) NO330134B1 (sl)
SI (1) SI1276759T1 (sl)
WO (1) WO2001083521A2 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
EP2753637A1 (en) 2011-09-09 2014-07-16 Sandoz AG Process for the synthesis of telavancin, its pharmaceutically acceptable salts as well as an n-protected imine-derivative of telavancin
WO2013034675A1 (en) 2011-09-09 2013-03-14 Sandoz Ag Process for the synthesis of telavancin and its pharmaceutically acceptable salts as well as n-protected derivatives thereof
CN103897040B (zh) * 2012-12-27 2018-05-22 浙江医药股份有限公司新昌制药厂 新型糖肽类化合物或其药用盐及其制备方法、以及药物组合物和用途
CN106188243B (zh) * 2015-05-05 2020-06-26 博瑞生物医药(苏州)股份有限公司 一种奥利万星的制备方法
WO2017194385A1 (en) 2016-05-09 2017-11-16 Xellia Pharmaceuticals Aps Stabilized glycopeptide antibiotic formulations
CN108409837B (zh) 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4644533A (en) * 1985-05-06 1987-02-17 American Telephone & Telegraph Company Packet switch trunk circuit queueing arrangement
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
ZA909847B (en) * 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
RU2145609C1 (ru) * 1994-01-28 2000-02-20 Эли Лилли Энд Компани Производные гликопептида или их соли, способ получения, фармацевтическая композиция
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5919756A (en) 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5952466A (en) * 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
ID18900A (id) * 1996-11-21 1998-05-20 Lilly Co Eli Alkilasi menurun dari gliko peptida anti biotik
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
AU3307399A (en) 1998-02-20 1999-09-06 Advanced Medicine, Inc. Novel antibacterial agents
WO2000039156A1 (en) 1998-12-23 2000-07-06 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
AU4054900A (en) 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
ES2302733T3 (es) * 2000-06-22 2008-08-01 Theravance, Inc. Derivados carboxi-sacaridos de glucopeptido.

Also Published As

Publication number Publication date
EP1276759A2 (en) 2003-01-22
EP1276759B1 (en) 2008-07-30
NO20025264D0 (no) 2002-11-01
US20020010131A1 (en) 2002-01-24
CN100532392C (zh) 2009-08-26
ATE402951T1 (de) 2008-08-15
JP4713810B2 (ja) 2011-06-29
KR100856479B1 (ko) 2008-09-04
JP2003531917A (ja) 2003-10-28
CA2407994A1 (en) 2001-11-08
CN1432023A (zh) 2003-07-23
ES2311014T3 (es) 2009-02-01
CA2407994C (en) 2010-02-02
DE60135102D1 (de) 2008-09-11
WO2001083521A3 (en) 2002-09-19
US6831150B2 (en) 2004-12-14
NO20025264L (no) 2002-12-18
AU2001257464A1 (en) 2001-11-12
NO330134B1 (no) 2011-02-21
JP2008222718A (ja) 2008-09-25
WO2001083521A2 (en) 2001-11-08
KR20020093110A (ko) 2002-12-12

Similar Documents

Publication Publication Date Title
HK1099031A1 (en) Method for purifying fsh fsh
MXPA02012931A (es) Proceso para preparar un elastomero.
TW200722033A (en) Pelvic clamp
SI1276759T1 (sl) Postopek reduktivnega alkiliranja na glikopeptidih
GB2368348B (en) Material for valve guides
GB2400690B (en) Fixture for an elevator system
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
AU2002328874A1 (en) Antioxidants for polyamides
HK1059760A1 (en) Fixing device.
HK1049171A1 (en) Selective n-acylation of a82846 glycopeptide analogs
MY122001A (en) Reducing agent for reductive alkylation of glycopeptide antibiotics
GB2378189B (en) Yarn feed apparatus
GB0120035D0 (en) System for article identification
AU2001293794A1 (en) A method for identifying peptide sequences having a specific functionality
GB2390600B (en) Pneumatic separating apparatus
IL156356A0 (en) A method for deprotecting a hydroxide or amine
HUP0202326A2 (en) Connecting device
MY123576A (en) Process for the selective n-formylation of n-hydroxylamines
ITBO980664A0 (it) Composizione , procedimento e apparecchiatura per la lucidatura di pez zi .
TW483525U (en) Testing mechanism for constant pressure
EP1373496A4 (en) METHODS OF IDENTIFYING PEPTIDES MODULATING A BIOLOGICAL PROCESS
IL144121A0 (en) Apparatus for pneumatic conveying
GB0123896D0 (en) Service matching system
TW507755U (en) Holding seat for sealing machine
TW504043U (en) Apparatus for holding wafers